Ask ABBO
Login
Sign up

Eli Lilly

Zepbound
Eli Lilly (NYSE: LLY) Introduces Vials of Weight-Loss Drug Zepbound Starting at $399 Per Month

On Tuesday, Eli Lilly (NYSE: LLY) said it has begun selling vials of the lowest starter dose of its popular

1 year ago

Eli Lilly
NHS Likely to Block Eli Lilly (NYSE: LLY) Alzheimer’s Treatment, The Telegraph Reports

Eli Lilly’s (NYSE: LLY) treatment for early Alzheimer’s is expected to be blocked for use by Britain’s National Health Service

1 year ago

Wegovy
Doctors Face Hurdles in Securing Wegovy for Older Americans with Heart Disease

NEW YORK – Older Americans are having little success getting prescriptions for the weight-loss drug Wegovy covered by Medicare despite

2 years ago

Roche
Roche to Fast-track Anti-Obesity Drug Development to Compete with Rivals: FT Report

Swiss drugmaker Roche plans to accelerate the development of its anti-obesity drugs to challenge rivals like Eli Lilly (NYSE: LLY)

2 years ago

Eli Lilly
Eli Lilly (NYSE: LLY) Secures FDA Approval for Alzheimer’s Drug

On Tuesday, the U.S. Food and Drug Administration approved Eli Lilly’s (NYSE: LLY) treatment for early Alzheimer’s, making it the

2 years ago

Load More